Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Think Research Corporation V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical... see more

TSXV:THNK - Post Discussion

Think Research Corporation > OTPP Launches Clinical Research Advancement Initiative
View:
Post by dt_core on Feb 09, 2024 2:26pm

OTPP Launches Clinical Research Advancement Initiative

Big move by OTPP. This is very interesting and potentially quite positive for THNK.



Linden Capital Partners and Ontario Teachers’ Pension Plan Launch Initiative Focused on Clinical Research Advancement

FEBRUARY 8, 2024 | FOR IMMEDIATE RELEASE

Chicago, IL and Toronto, Ont. (February 8, 2024) -Linden Capital Partners (Linden) and Ontario Teachers’ Pension Plan (Ontario Teachers’) are pleased to announce they are partnering on a transformative platform, led by Dr. John Potthoff, with the goal of revolutionizing the clinical research ecosystem. This strategic initiative is centered around investing in exceptional companies and deploying cutting-edge technology to foster seamless connections and collaborations among patients, research sites, pharmaceutical companies, and the broader clinical research community.

The platform will be led by Dr. John Potthoff, who is currently the Chairperson of Elligo Health Research®. He has more than 30 years of leadership and operational experience in the life sciences and pharmaceutical services sectors. Dr. Potthoff has successfully scaled and grown businesses as a founder, entrepreneur, and CEO.

“We believe our collaboration is a potential game-changer for clinical research. We see a significant gap in the industry and believe this strategic alliance will drive meaningful change and opportunity,” said Dr. Potthoff. “By integrating leading companies and leveraging advanced technologies, we aim to create a cohesive and interconnected clinical research environment. Recognizing the unique needs of each therapeutic and scientific area, we aim to streamline processes, enhance efficiencies, and foster collaborations that benefit all stakeholders, especially patients.”

The initiative will be chaired by Ms. Margaret Keegan, an industry luminary with prior executive roles across all functions of clinical development at large pharmaceutical and CRO companies, including PPD, IQVIA and PRA Health Sciences. Ms. Keegan is the former Chair of the Board for CDISC (Clinical Data Interchange Standards Consortium), the clinical research data standards organization and currently serves as CEO of RQM+. “I am excited to collaborate with Dr. Potthoff, Linden, and Ontario Teachers’ to realize our shared vision,” expressed Ms. Keegan. “We recognize the inefficiencies and shortcomings of clinical research services that impact patients, research sites, sponsors, and regulators, leading to delays in getting critical therapies to patients in need. Our commitment is to address these challenges head-on and catalyze positive change in our industry.”

Vision for a Unified Clinical Research Ecosystem: The initiative is dedicated to building a more unified and efficient clinical research ecosystem. Through strategic M&A and the deployment of technology, it will seek to enhance collaboration across all aspects of clinical research, from patient engagement through regulatory submissions, ensuring that every phase of the research process is seamlessly connected and optimized.

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities